Objectives To analyze the oncological and functional outcomes of patients with stage III-IV
laryngo-hypopharyngeal cancer who underwent neoadjuvant chemotherapy (NAC) with …

Background We conducted a prospective clinical trial of combination neoadjuvant
chemotherapy, transoral robotic surgery (TORS), and customized adjuvant therapy in …

Background We aimed to identify the optimal indications of neoadjuvant chemotherapy
(NACT) and transoral robotic surgery (TORS) in patients with locoregionally advanced (T3‐4 …

Background A prospective clinical trial of combination neoadjuvant chemotherapy, transoral
robotic surgery (TORS), and customized adjuvant therapy for patients with locally advanced …

Background This study presents oncologic outcomes after transoral robotic surgery
(TORS)±adjuvant therapy for oropharyngeal squamous cell carcinoma (SCC). Methods …

Transoral robotic surgery (TORS) has been used for treating pharyngeal and laryngeal
cancers for many years. However, the application of neoadjuvant chemotherapy (NACT) …

Objectives To determine the oncologic and functional outcomes in patients undergoing
primary transoral robotic surgery followed by adjuvant therapy as indicated with a minimum …

Objectives/Hypothesis To assess adjuvant therapy in patients undergoing surgical
management of oropharyngeal squamous cell carcinoma (OPSCCA) with transoral robotic …

Purpose Optimal treatment strategies for the management of oropharyngeal squamous cell
carcinoma (OPSCC) remain unclear. The objective of this study is to examine the role of …

Objectives The aim of this multicenter retrospective cohort study was to compare efficacy
and subsequent postoperative treatment between transoral robotic surgery (TORS) and any …